Physician profile
Abdullah Bin Munir
NPI 1750760195
$4,808.90
in general payments reported to CMS, 2019-2025
31 companies · $1,740 in 2025
The $1,740 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $334 · 2023: $991 · 2024: $1,745 · 2025: $1,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,455 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,455.17 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $792.28 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $654.58 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Abiomed | $536.95 | 2023-2025 | Impella |
| Boston Scientific Corporation | $446.20 | 2024-2025 | Avvigo Guidance System, General - Balloon Catheters, Varithena Administration Pack |
| Novartis Pharmaceuticals Corporation | $262.12 | 2024-2025 | |
| Inari Medical, INC. | $244.68 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $232.42 | 2022-2024 | Corevalve Evolut R, Onyx Frontier, Venaseal |
| E.R. Squibb & Sons, L.L.C. | $217.49 | 2023-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $173.34 | 2023-2025 | Assure Wcd |
| Cardiovascular Systems INC. | $148.00 | 2022 | |
| Abbott Laboratories | $142.20 | 2024-2025 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.07 | 2023-2025 | Lifevest |
| Surmodics, INC. | $101.28 | 2024-2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy |
| Novo Nordisk INC | $89.97 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Becton, Dickinson and Company | $72.79 | 2023-2024 | Venclose Maven Catheter |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $63.63 | 2025 | |
| Scpharmaceuticals INC. | $62.07 | 2025 | |
| Janssen Pharmaceuticals, INC | $59.61 | 2023 | Xarelto |
| Amgen INC. | $52.45 | 2025 | Repatha |
| Pfizer INC. | $51.15 | 2024 | |
| Cardiac Dimensions, INC. | $50.81 | 2025 | |
| Philips North America LLC | $41.64 | 2022-2025 | Pioneer |
| Bard Peripheral Vascular, INC. | $40.65 | 2023-2024 | Venclose Maven Catheter |
| Zoll Circulation INC | $34.81 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Biotronik INC. | $28.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $28.33 | 2024 | Farxiga |
| Inspire Medical Systems, INC. | $17.60 | 2025 | Inspire |
| Cordis US Corp. | $17.08 | 2025 | Mynx Control Venous |
| Stryker Corporation | $16.71 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.54 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $13.11 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdullah Bin Munir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.